AngioDynamics
ANGO
164 hedge funds and large institutions have $626M invested in AngioDynamics in 2018 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 23 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 48
1.09% more ownership
Funds ownership: 97.69% → 98.78% (+1.1%)
5% more capital invested
Capital invested by funds: $597M → $626M (+$29.7M)
3% less funds holding
Funds holding: 169 → 164 (-5)
13% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 23
99% less call options, than puts
Call options by funds: $4K | Put options by funds: $462K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$13.5M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$9.29M |
| 3 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$6.36M |
| 4 |
BlackRock
New York
|
+$6.23M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$5.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$13.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.98M |
| 3 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
-$9.2M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$8.58M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$3.86M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
176
Capital Fund Management (CFM)
Paris,
France
| – | -$181K | -10,900 | Closed |
|
|
CGH
177
Crossmark Global Holdings
Houston,
Texas
| – | -$172K | -10,352 | Closed |
|
|
SCM
178
Stevens Capital Management
Radnor,
Pennsylvania
| – | -$167K | -10,018 | Closed |
|
179
Parallax Volatility Advisers
San Francisco,
California
| – | -$93K | -5,586 | Closed |
|
|
AG
180
Advisor Group
Phoenix,
Arizona
| – | -$17K | -1,000 | Closed |
|
|
DCM
181
Delpha Capital Management
New York
| – | -$14K | -846 | Closed |
|
|
TRCT
182
Tower Research Capital (TRC)
New York
| – | -$13K | -776 | Closed |
|
|
FMA
183
FNY Managed Accounts
New York
| – | -$5.29K | -317 | -97% |
|
184
SEI Investments
Oaks,
Pennsylvania
| – | -$1K | -70 | Closed |
|
ANGO Hedge Fund Activity: Q1 2018 in Review
164 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q1 2018, worth a combined $626M — up 5% from $597M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ANGO and 20 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 67 added.
The largest buyer was JP Morgan Chase, adding an estimated $13.5M. The largest seller was Broadfin Capital, cutting an estimated $13.7M.
- 164 institutional investors held AngioDynamics (ANGO) as of Q1 2018, down from 169 in Q4 2017.
- Funds reported $626M of AngioDynamics stock for Q1 2018, up 5% quarter-over-quarter.
- 20 funds opened new AngioDynamics positions in Q1 2018 and 23 closed out, a net change of -3 holders.
- The largest AngioDynamics buyer in Q1 2018 was JP Morgan Chase, an estimated $13.5M added.
- The largest AngioDynamics seller in Q1 2018 was Broadfin Capital, an estimated $13.7M sold.
Based on aggregated 13F filings for Q1 2018.